Abstract: COVID FAQ
By Steve Kirsch
Last updated: March 6, 2021
Disclaimer: The views expressed in this article are my own personal opinion based on my
1,000+ hour study of cutting edge research. The science is rapidly developing and this
document may change over time. Please do not take any drugs or other actions mentioned in
this article without seeking advice from a qualified medical professional.
Table of Contents
About this document
Who are you?
Why are you writing this?
What do you recommend if I have COVID?
I’m in the ICU with COVID. What should I do?
What are the most important points to note other than the drugs and dosing?
What do you recommend if I’ve had COVID, but still have symptoms, i.e, long-haul COVID?
What is the fluvoxamine prescribing information?
What are fluvoxamine drug interactions?
When should I start the drugs?
If I take the drugs, can I still die from COVID?
I have low risk factors. Do I need to take any drugs?
Is it legal for you to talk about using drugs for indications that aren’t approved by the FDA?
If this is such a great treatment, why haven’t Stanford, Harvard, UCSF, and other institutions
added this to their clinical practice guidelines?
If this works so well, why haven’t I read extensively about it in the press? Shouldn’t everyone
What is the evidence supporting fluvoxamine as a COVID treatment?
Actual experience of doctors prescribing ivermectin who added FLV as a second drug
Additional supporting evidence
Shouldn’t we wait for more evidence like the Phase 3 study results before doctors start
prescribing this drug? Or wait for this to be on the NIH guidelines?
NIH Director Francis Collins compared fluvoxamine with hydroxychloroquine on CNN. Is he
What is the evidence for ivermectin?
Are there any drugs that are as good as or better than fluvoxamine to treat COVID early?
Does fluvoxamine help with COVID symptoms or just hospitalization risk?
How does fluvoxamine work? What are the 8 mechanisms of action?
What do infectious disease experts think?
Have you applied for an EUA?
Is there a Phase 3 clinical trial for fluvoxamine?
Have other SSRIs been tested?
Who else is writing about fluvoxamine?
What’s the probability we save more lives if we start prescribing fluvoxamine?
Where can I find out more information?
About this document
This document contains answers to more detailed questions than I covered in the How I would
treat COVID document. You should definitely read that document first.
Who are you?
I’m a serial entrepreneur and philanthropist and founder of COVID-19 Early Treatment
I’m a serial high-tech entrepreneur and philanthropist. I have started 7 high tech companies, two
with billion dollar market caps. I have a SM and SB in EECS from MIT. More about me on
Wikipedia and LinkedIn.
When the lockdown began, I took a leave of absence and started an organization, COVID-19
Early Treatment Fund, that funds research on using repurposed drugs to treat COVID. We
raised $5M, received 60 grant applications and funded 14. I chose that approach because I
thought it would be the fastest and cheapest way to end the pandemic. Once we find a drug
combination that reduces the hospitalization/death rate from COVID by more than a factor of 10,
we should be able much more rapidly get back to normal.
For more, watch this 3 minute intro: COVID-19 Early Treatment Fund (CETF) Introduction YouTube.
I was featured in a front page story in the LA Times about COVID..
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Vaccines and treatments are complementary. All practical, effective, and safe
means should be used based on risk/benefit analysis. No treatment, vaccine, or
intervention is 100% available and effective for all current and future
variants. We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.